Search
In 2020, we celebrated our 30th birthday with those who matter most — the kids whose lives we’ve changed through the research we do.
While individual diseases are rare, as a group, rare diseases are common. Recent estimates suggest that between 3% and 6% of the world’s population are affected by rare disease.
Early intervention is being touted as the key to preventing lung damage in children with cystic fibrosis.
Hope ahead for children with CF, as life expectancy continues to grow thanks to research.
Our showcase projects are a demonstration of how we at The Kids Research Institute Australia are committed to a new way of working.
Learn more about all of the Clinical Trials, Platforms & Cohorts at the Wal-yan respiratory centre.
Cystic fibrosis (CF) is the most common life‐shortening genetic disease affecting children.
Caregivers of individuals with neurodevelopmental and chronic health conditions require health literacy (HL) skills for the long-term management of these conditions. The aim of this rapid review was to investigate the efficacy of HL interventions for these caregivers.
To establish the burden of respiratory illness in cerebral palsy (CP) on the Western Australian health care system by quantifying the costs of respiratory hospitalizations in children with CP, compared with non-respiratory hospitalizations.
To investigate the potential risk factors of respiratory illness (ethnicity, oral health, and eating and drinking ability) in children and young adults with cerebral palsy.